Squarepoint Ops LLC Coherus Bio Sciences, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.58 - $2.51 $90,635 - $143,983	-57,364 Reduced 84.89%	10,214 $17,000
Q1 2024 May 15, 2024	SELL	$2.02 - $3.14 $188,964 - $293,737	-93,547 Reduced 58.06%	67,578 $161,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $197,498 - $478,220	-124,213 Reduced 43.53%	161,125 $536,000
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $748,483 - $1.64 Million	197,489 Added 224.81%	285,338 $1.22 Million
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $319,732 - $571,067	54,284 Added 161.73%	87,849 $600,000
Q4 2022 Feb 14, 2023	SELL	$5.69 - $10.07 $221,602 - $392,186	-38,946 Reduced 53.71%	33,565 $265,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $519,903 - $1.01 Million	72,511 New	72,511 $697,000
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $1.47 Million - $2.07 Million	-116,257 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $1.51 Million - $1.79 Million	116,257 New	116,257 $1.61 Million
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $320,902 - $476,013	-22,254 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$16.56 - $18.94 $368,526 - $421,490	22,254 New	22,254 $387,000
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $283,434 - $323,809	-16,280 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $1.3 Million - $1.73 Million	-90,085 Reduced 84.69%	16,280 $291,000
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $161,524 - $311,837	13,841 Added 14.96%	106,365 $1.73 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $1.02 Million - $1.34 Million	62,683 Added 210.06%	92,524 $1.67 Million
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $810,631 - $1.16 Million	-49,732 Reduced 62.5%	29,841 $605,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $54,810 - $92,466	4,184 Added 5.55%	79,573 $1.76 Million
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $631,759 - $1.17 Million	75,389 New	75,389 $1.03 Million
Q4 2018 Feb 14, 2019	SELL	$8.65 - $16.28 $179,747 - $338,298	-20,780 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $300,271 - $420,795	20,780 New	20,780 $343,000
Q1 2018 May 15, 2018	SELL	$9.1 - $13.7 $209,591 - $315,538	-23,032 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.35 - $14.4 $56,279 - $97,056	6,740 Added 41.37%	23,032 $203,000
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $180,841 - $236,234	16,292	16,292 $217,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$8.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$8.37 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$7.7 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$2.25 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$2.11 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $57.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account